K943996

Substantially Equivalent

DUPONT ACA PLUS LUTEINIZING HORMONE (LH) METHOD

Applicant: Dupont Medical Products
Product code: CEP
Advisory panel: Clinical Chemistry
Date received: 1994-08-16
Decision date: 1994-10-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: N. Billerica, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.